Diabetic neuropathy: pathogenetic background, current and future therapies.

  title={Diabetic neuropathy: pathogenetic background, current and future therapies.},
  author={Anders A. F. Sima},
  journal={Expert review of neurotherapeutics},
  volume={1 2},
Diabetic neuropathy is the most common complication in diabetes. To date, there are few efficacious therapies for this complication. Several groups of drugs have undergone clinical testing, the outcome of which has not yielded convincing benefits. Diabetic neuropathy is a dynamic chronic degenerative disorder with multiple interactive pathogenetic mechanisms complicating the design of biologically-meaningful therapies. New insights into this disorder and the fact that it differs in the two… CONTINUE READING


Publications referenced by this paper.
Showing 1-10 of 131 references

Altered immediate gene expression is impaired in diabetic nerve; implications in regeneration

  • G Xu, Sima AAF
  • J. Neuropath. Exp. Neurol
  • 2001

Beneficial effects of Cpeptide on incipient nephropathy and neuropathy in patients with Type 1 diabetesa three - month study

  • BL Johansson, K Borg, E Fernquist-Forbes, A Kernell, T Odergren, J Wahren
  • Diabetic Medicine
  • 2000

Similar Papers

Loading similar papers…